Aspira Pathlab promoter Jay Arvind Bhanushali acquires 957 shares
- Promoter Jay Arvind Bhanushali bought 957 shares via open market
- Stake increased from 7.24% to 7.25% in the diagnostics firm
- Total holding stands at 7,45,754 equity shares post-acquisition
- Disclosure filed under SEBI SAST Regulation 29(2)
*this image is generated using AI for illustrative purposes only.
Promoter Jay Arvind Bhanushali acquired 957 equity shares of Aspira Pathlab on August 31, 2026, through open market transactions. The purchase represents a 0.01% increase in his voting stake.
The acquisition was disclosed to the BSE Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Bhanushali’s total holding rose from 7,44,797 shares (7.24%) to 7,45,754 shares (7.25%).
What the Numbers Show
The transaction involved only equity shares carrying voting rights. There were no changes in encumbered shares, warrants, or convertible securities. The company’s total equity share capital remained unchanged at ₹10,29,30,000, divided into 1,02,93,000 equity shares of ₹10 each.
Historical Stock Returns for Aspira Pathlab
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.32% | +2.27% | -23.83% | +57.89% | +47.32% | +53.45% |
Does this incremental purchase signal Jay Arvind Bhanushali's confidence in Aspira Pathlab's upcoming financial performance or strategic initiatives?
How might this slight increase in promoter holding influence retail investor sentiment and short-term stock price volatility?
Are there indications that the promoter plans further open market acquisitions to consolidate control in the near future?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
